Recordati reported EUR672M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Almirall EUR 602.71M 55.09M Jun/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Orion EUR 542.2M 20.6M Sep/2026
Sanofi EUR 14.44B 2.49B Sep/2026